J. Russell

发表

Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site.

I. Olver, D. Keefe, F. Parnis, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

First-line (1L) avelumab treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Preliminary data from an ongoing study.

S. D'Angelo, C. Lebbé, P. Terheyden, 2017 .

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial

S. D'Angelo, M. Burgess, J. Grob, 2020, The Patient - Patient-Centered Outcomes Research.

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma

S. Glück, P. Forsyth, T. Cheng, 2003, Bone Marrow Transplantation.

Combination chemotherapy of metastatic breast cancer with vincristine, adriamycin and prednisolone

T. Powles, J. Gazet, J. Mckinna, 1978, Cancer.

Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.

N. Iscoe, I. Quirt, W. Shelley, 1985, Cancer treatment reports.

Is mortality due to primary malignant brain and other central nervous system tumors decreasing?

J. Barnholtz-Sloan, Q. Ostrom, H. Gittleman, 2017, Journal of Neuro-Oncology.